Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
QT Imaging Holdings, Inc. (QT Imaging) recently announced that the enhanced configuration of its breast acoustic CT scanner has received market approval from the U.S. Food and Drug Administration (FDA).

QT Imaging Holdings, Inc. (QT Imaging) recently announced that the enhanced configuration of its breast acoustic CT scanner has received market approval from the U.S. Food and Drug Administration (FDA).

老虎证券老虎证券2026/03/10 13:31
Show original
This new configuration is specifically optimized and upgraded for imaging coverage of the posterior breast tissue, and is expected to significantly enhance the detection capability for lesions in the posterior breast region. FDA approval means that this enhanced scanner can now be officially used in clinical practice in the US market, providing more comprehensive imaging support for the early diagnosis of breast diseases.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

SK hynix (SKHY.US) subsidiary Flash Division reportedly selects Goldman Sachs and Morgan Stanley to lead, aiming for a US IPO in 2027

According to sources familiar with the matter, Solidigm, the flash memory subsidiary of SK hynix (SKHY.US), has selected the lead banks for its planned US IPO next year, with Goldman Sachs and Morgan Stanley responsible for the offering.

智通财经•2026/10/08 02:56

KS Industry holds extraordinary shareholder meeting, elects directors

KS Industry held an extraordinary shareholder meeting on Oct. 8, 2026. Shareholders passed resolutions to appoint Kim In-gyeom as an internal director. Approval was also secured to appoint Chen Yang as an internal director. Resolutions to appoint Kim Woo-joon, Cha Haeng-jeon as independent directors were adopted. The votes authorized these board appointments; the filing did not confirm the appointments have been implemented. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KS Industry Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008900252), on October 08, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/08 02:43

Pfizer (PFE.US) Tukysa approved in the United States for first-line breast cancer treatment

Pfizer (PFE.US) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has approved its tyrosine kinase inhibitor, Tukysa (tucatinib), as part of a combination regimen for first-line maintenance treatment of a certain type of breast cancer.

智通财经•2026/10/08 02:43